青光眼发病机制与治疗研究进展
Advances in Glaucoma Pathogenesis and Treatment
DOI: 10.12677/jcpm.2025.42175, PDF,   
作者: 刘钰洁:济宁医学院临床医学院(附属医院),山东 济宁;周亚兰*:济宁医学院附属医院眼科,山东 济宁
关键词: 青光眼发病机制治疗Glaucoma Pathogenesis Treatment
摘要: 青光眼作为全球不可逆视力丧失的主要原因之一,在临床实践和研究中引起了广泛的关注,而常规的治疗方法并不能完全治愈青光眼,因此寻求新的青光眼治疗手段显得尤为重要。该综述旨在系统回顾青光眼的发病机制并对其新进展进行分析,进一步完善青光眼的发病机制,从而为青光眼的治疗提供新思路。
Abstract: Glaucoma, as one of the major causes of irreversible vision loss worldwide, has attracted widespread attention in clinical practice and research, and as conventional treatments do not completely cure glaucoma, the search for new glaucoma treatments is of particular importance. The aim of this review is to systematically review the pathogenesis of glaucoma and analyze its new developments to further improve the pathogenesis of glaucoma, thus providing new ideas for the treatment of glaucoma.
文章引用:刘钰洁, 周亚兰. 青光眼发病机制与治疗研究进展[J]. 临床个性化医学, 2025, 4(2): 279-286. https://doi.org/10.12677/jcpm.2025.42175

参考文献

[1] Quigley, H.A. (2006) The Number of People with Glaucoma Worldwide in 2010 and 2020. British Journal of Ophthalmology, 90, 262-267. [Google Scholar] [CrossRef] [PubMed]
[2] Tham, Y., Li, X., Wong, T.Y., Quigley, H.A., Aung, T. and Cheng, C. (2014) Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis. Ophthalmology, 121, 2081-2090. [Google Scholar] [CrossRef] [PubMed]
[3] Shan, S., Wu, J., Cao, J., Feng, Y., Zhou, J., Luo, Z., et al. (2024) Global Incidence and Risk Factors for Glaucoma: A Systematic Review and Meta-Analysis of Prospective Studies. Journal of Global Health, 14, Article ID: 04252 [Google Scholar] [CrossRef] [PubMed]
[4] Stein, J.D., Khawaja, A.P. and Weizer, J.S. (2021) Glaucoma in Adults—Screening, Diagnosis, and Management: A Review. JAMA, 325, 164-174. [Google Scholar] [CrossRef] [PubMed]
[5] Jindal, V. (2013) Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders. Molecular Neurobiology, 48, 186-189. [Google Scholar] [CrossRef] [PubMed]
[6] Wareham, L.K., Liddelow, S.A., Temple, S., Benowitz, L.I., Di Polo, A., Wellington, C., et al. (2022) Solving Neurodegeneration: Common Mechanisms and Strategies for New Treatments. Molecular Neurodegeneration, 17, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[7] Carreon, T., van der Merwe, E., Fellman, R.L., Johnstone, M. and Bhattacharya, S.K. (2017) Aqueous Outflow—A Continuum from Trabecular Meshwork to Episcleral Veins. Progress in Retinal and Eye Research, 57, 108-133. [Google Scholar] [CrossRef] [PubMed]
[8] Last, J.A., Pan, T., Ding, Y., Reilly, C.M., Keller, K., Acott, T.S., et al. (2011) Elastic Modulus Determination of Normal and Glaucomatous Human Trabecular Meshwork. Investigative Opthalmology & Visual Science, 52, 2147-2152. [Google Scholar] [CrossRef] [PubMed]
[9] Munaron, L. (2011) Shuffling the Cards in Signal Transduction: Calcium, Arachidonic Acid and Mechanosensitivity. World Journal of Biological Chemistry, 2, 59-66. [Google Scholar] [CrossRef] [PubMed]
[10] Tamm, E.R. (2009) The Trabecular Meshwork Outflow Pathways: Structural and Functional Aspects. Experimental Eye Research, 88, 648-655. [Google Scholar] [CrossRef] [PubMed]
[11] Morozumi, W., Aoshima, K., Inagaki, S., Iwata, Y., Nakamura, S., Hara, H., et al. (2021) Piezo 1 Is Involved in Intraocular Pressure Regulation. Journal of Pharmacological Sciences, 147, 211-221. [Google Scholar] [CrossRef] [PubMed]
[12] Faralli, J.A., Filla, M.S. and Peters, D.M. (2019) Role of Fibronectin in Primary Open Angle Glaucoma. Cells, 8, Article 1518. [Google Scholar] [CrossRef] [PubMed]
[13] Quigley, H.A. and Cone, F.E. (2013) Development of Diagnostic and Treatment Strategies for Glaucoma through Understanding and Modification of Scleral and Lamina Cribrosa Connective Tissue. Cell and Tissue Research, 353, 231-244. [Google Scholar] [CrossRef] [PubMed]
[14] Nakazawa, T. and Fukuchi, T. (2020) What Is Glaucomatous Optic Neuropathy? Japanese Journal of Ophthalmology, 64, 243-249. [Google Scholar] [CrossRef] [PubMed]
[15] Alarcon-Martinez, L., Shiga, Y., Villafranca-Baughman, D., Cueva Vargas, J.L., Vidal Paredes, I.A., Quintero, H., et al. (2023) Neurovascular Dysfunction in Glaucoma. Progress in Retinal and Eye Research, 97, Article ID: 101217. [Google Scholar] [CrossRef] [PubMed]
[16] Casson, R.J., Chidlow, G., Crowston, J.G., Williams, P.A. and Wood, J.P.M. (2021) Retinal Energy Metabolism in Health and Glaucoma. Progress in Retinal and Eye Research, 81, Article ID: 100881. [Google Scholar] [CrossRef] [PubMed]
[17] Wareham, L.K. and Calkins, D.J. (2020) The Neurovascular Unit in Glaucomatous Neurodegeneration. Frontiers in Cell and Developmental Biology, 8, Article 452. [Google Scholar] [CrossRef] [PubMed]
[18] Pillunat, K.R., Ventzke, S., Spoerl, E., Furashova, O., Stodtmeister, R. and Pillunat, L.E. (2014) Central Retinal Venous Pulsation Pressure in Different Stages of Primary Open-Angle Glaucoma. British Journal of Ophthalmology, 98, 1374-1378. [Google Scholar] [CrossRef] [PubMed]
[19] Leeman, M. and Kestelyn, P. (2019) Glaucoma and Blood Pressure. Hypertension, 73, 944-950. [Google Scholar] [CrossRef] [PubMed]
[20] Sen, S., Saxena, R., Tripathi, M., Vibha, D. and Dhiman, R. (2020) Neurodegeneration in Alzheimer’s Disease and Glaucoma: Overlaps and Missing Links. Eye, 34, 1546-1553. [Google Scholar] [CrossRef] [PubMed]
[21] Asefa, N.G., Neustaeter, A., Jansonius, N.M. and Snieder, H. (2019) Heritability of Glaucoma and Glaucoma-Related Endophenotypes: Systematic Review and Meta-Analysis. Survey of Ophthalmology, 64, 835-851. [Google Scholar] [CrossRef] [PubMed]
[22] Zukerman, R., Harris, A., Oddone, F., Siesky, B., Verticchio Vercellin, A. and Ciulla, T.A. (2021) Glaucoma Heritability: Molecular Mechanisms of Disease. Genes, 12, Article 1135. [Google Scholar] [CrossRef] [PubMed]
[23] D’Esposito, F., Gagliano, C., Bloom, P., Cordeiro, M., Avitabile, A., Gagliano, G., et al. (2024) Epigenetics in Glaucoma. Medicina, 60, Article 905. [Google Scholar] [CrossRef] [PubMed]
[24] Alkozi, H.A., Franco, R. and Pintor, J.J. (2017) Epigenetics in the Eye: An Overview of the Most Relevant Ocular Diseases. Frontiers in Genetics, 8, Article 144. [Google Scholar] [CrossRef] [PubMed]
[25] McDonnell, F., O’Brien, C. and Wallace, D. (2014) The Role of Epigenetics in the Fibrotic Processes Associated with Glaucoma. Journal of Ophthalmology, 2014, Article ID: 750459. [Google Scholar] [CrossRef] [PubMed]
[26] Geyer, O. and Levo, Y. (2020) Glaucoma Is an Autoimmune Disease. Autoimmunity Reviews, 19, Article ID: 102535. [Google Scholar] [CrossRef] [PubMed]
[27] Wang, L. and Wei, X. (2021) T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration. Frontiers in Immunology, 12, Article 803485. [Google Scholar] [CrossRef] [PubMed]
[28] Wei, X., Cho, K., Thee, E.F., Jager, M.J. and Chen, D.F. (2018) Neuroinflammation and Microglia in Glaucoma: Time for a Paradigm Shift. Journal of Neuroscience Research, 97, 70-76. [Google Scholar] [CrossRef] [PubMed]
[29] Tezel, G. (2022) Molecular Regulation of Neuroinflammation in Glaucoma: Current Knowledge and the Ongoing Search for New Treatment Targets. Progress in Retinal and Eye Research, 87, Article ID: 100998. [Google Scholar] [CrossRef] [PubMed]
[30] Takeda, A., Shinozaki, Y., Kashiwagi, K., Ohno, N., Eto, K., Wake, H., et al. (2018) Microglia Mediate Non-Cell-Autonomous Cell Death of Retinal Ganglion Cells. Glia, 66, 2366-2384. [Google Scholar] [CrossRef] [PubMed]
[31] Harada, T., Harada, C., Nakamura, K., Quah, H.A., Okumura, A., Namekata, K., et al. (2007) The Potential Role of Glutamate Transporters in the Pathogenesis of Normal Tension Glaucoma. Journal of Clinical Investigation, 117, 1763-1770. [Google Scholar] [CrossRef] [PubMed]
[32] Ji, M., Miao, Y., Dong, L., Chen, J., Mo, X., Jiang, S., et al. (2012) Group I mGluR-Mediated Inhibition of Kir Channels Contributes to Retinal Müller Cell Gliosis in a Rat Chronic Ocular Hypertension Model. The Journal of Neuroscience, 32, 12744-12755. [Google Scholar] [CrossRef] [PubMed]
[33] Shinozaki, Y. and Koizumi, S. (2021) Potential Roles of Astrocytes and Müller Cells in the Pathogenesis of Glaucoma. Journal of Pharmacological Sciences, 145, 262-267. [Google Scholar] [CrossRef] [PubMed]
[34] Ju, W., Perkins, G.A., Kim, K., Bastola, T., Choi, W. and Choi, S. (2023) Glaucomatous Optic Neuropathy: Mitochondrial Dynamics, Dysfunction and Protection in Retinal Ganglion Cells. Progress in Retinal and Eye Research, 95, Article ID: 101136. [Google Scholar] [CrossRef] [PubMed]
[35] Bader, V. and Winklhofer, K.F. (2020) Mitochondria at the Interface between Neurodegeneration and Neuroinflammation. Seminars in Cell & Developmental Biology, 99, 163-171. [Google Scholar] [CrossRef] [PubMed]
[36] van Horssen, J., van Schaik, P. and Witte, M. (2019) Inflammation and Mitochondrial Dysfunction: A Vicious Circle in Neurodegenerative Disorders? Neuroscience Letters, 710, Article ID: 132931. [Google Scholar] [CrossRef] [PubMed]
[37] Duarte, J.N. (2021) Neuroinflammatory Mechanisms of Mitochondrial Dysfunction and Neurodegeneration in Glaucoma. Journal of Ophthalmology, 2021, Article ID: 4581909. [Google Scholar] [CrossRef] [PubMed]
[38] Tezel, G. (2021) Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects. Cells, 10, Article 1372. [Google Scholar] [CrossRef] [PubMed]
[39] He, S., Stankowska, D.L., Ellis, D.Z., Krishnamoorthy, R.R. and Yorio, T. (2018) Targets of Neuroprotection in Glaucoma. Journal of Ocular Pharmacology and Therapeutics, 34, 85-106. [Google Scholar] [CrossRef] [PubMed]
[40] Weinreb, R.N., Leung, C.K.S., Crowston, J.G., Medeiros, F.A., Friedman, D.S., Wiggs, J.L., et al. (2016) Primary Open-Angle Glaucoma. Nature Reviews Disease Primers, 2, Article No. 16067. [Google Scholar] [CrossRef] [PubMed]
[41] Zaher, O., Kuchtaruk, A.A., McGinnis, E.S., Paunic, M. and Malvankar-Mehta, M.S. (2024) Effect of Various Relaxation Techniques on the Intraocular Pressure of Patients with Glaucoma: Systematic Review and Meta-Analysis. Canadian Journal of Ophthalmology, 59, e343-e349. [Google Scholar] [CrossRef] [PubMed]
[42] Dada, T., Bhai, N., Midha, N., Shakrawal, J., Kumar, M., Chaurasia, P., et al. (2021) Effect of Mindfulness Meditation on Intraocular Pressure and Trabecular Meshwork Gene Expression: A Randomized Controlled Trial. American Journal of Ophthalmology, 223, 308-321. [Google Scholar] [CrossRef] [PubMed]
[43] Dada, T., Lahri, B., Mahalingam, K., Shakrawal, J., Kumar, A., Sihota, R., et al. (2021) Beneficial Effect of Mindfulness Based Stress Reduction on Optic Disc Perfusion in Primary Open Angle Glaucoma: A Randomized Controlled Trial. Journal of Traditional and Complementary Medicine, 11, 581-586. [Google Scholar] [CrossRef] [PubMed]
[44] Weinreb, R.N., Aung, T. and Medeiros, F.A. (2014) The Pathophysiology and Treatment of Glaucoma. JAMA, 311, 1901-1911. [Google Scholar] [CrossRef] [PubMed]
[45] Lindén, C. and Alm, A. (1999) Prostaglandin Analogues in the Treatment of Glaucoma. Drugs & Aging, 14, 387-398. [Google Scholar] [CrossRef] [PubMed]
[46] Alm, A., Grierson, I. and Shields, M.B. (2008) Side Effects Associated with Prostaglandin Analog Therapy. Survey of Ophthalmology, 53, S93-S105. [Google Scholar] [CrossRef] [PubMed]
[47] Brooks, A.M.V. and Gillies, W.E. (1992) Ocular β-Blockers in Glaucoma Management. Clinical Pharmacological Aspects. Drugs & Aging, 2, 208-221. [Google Scholar] [CrossRef] [PubMed]
[48] Clement Freiberg, J., von Spreckelsen, A., Kolko, M., Azuara-Blanco, A. and Virgili, G. (2022) Rho Kinase Inhibitor for Primary Open-Angle Glaucoma and Ocular Hypertension. Cochrane Database of Systematic Reviews, 6, CD013817. [Google Scholar] [CrossRef] [PubMed]
[49] Kahook, M.Y., Serle, J.B., Mah, F.S., Kim, T., Raizman, M.B., Heah, T., et al. (2019) Long-Term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (Rocket-2). American Journal of Ophthalmology, 200, 130-137. [Google Scholar] [CrossRef] [PubMed]
[50] Yadav, K.S., Rajpurohit, R. and Sharma, S. (2019) Glaucoma: Current Treatment and Impact of Advanced Drug Delivery Systems. Life Sciences, 221, 362-376. [Google Scholar] [CrossRef] [PubMed]
[51] Liu, X.Y. and Sun, X.H. (2024) Research Progress of Retinal Neuroprotective Drugs for Glaucoma. Chinese Journal of Ophthalmology, 60, 860-869.
[52] Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., Garg, A., Vickerstaff, V., Hunter, R., et al. (2019) Selective Laser Trabeculoplasty versus Eye Drops for First-Line Treatment of Ocular Hypertension and Glaucoma (Light): A Multicentre Randomised Controlled Trial. The Lancet, 393, 1505-1516. [Google Scholar] [CrossRef] [PubMed]
[53] Lim, R. (2022) The Surgical Management of Glaucoma: A Review. Clinical & Experimental Ophthalmology, 50, 213-231. [Google Scholar] [CrossRef] [PubMed]
[54] Gedde, S.J., Herndon, L.W., Brandt, J.D., Budenz, D.L., Feuer, W.J. and Schiffman, J.C. (2012) Postoperative Complications in the Tube versus Trabeculectomy (TVT) Study during Five Years of Follow-Up. American Journal of Ophthalmology, 153, 804-814.e1. [Google Scholar] [CrossRef] [PubMed]